临床肿瘤学杂志

• 论著 • 上一篇    下一篇

肺癌与食管癌螺旋断层放疗致放射性肺炎的临床观察

姚波,王雅棣,刘清志,路娜,陈点点   

  1. 100700 北京 北京军区总医院放疗科
  • 收稿日期:2013-07-22 修回日期:2013-09-02 出版日期:2014-01-31 发布日期:2014-01-31

Radiation pneumonitis in patients with lung cancer and esophageal cancer treated by helical tomotherapy

YAO Bo, WANG Yadi, LIU Qingzhi, LU Na, CHEN Diandian   

  1. Department of Radiation Oncology, General Hospital of Beijing Military Command, PLA, Beijing 100700, China
  • Received:2013-07-22 Revised:2013-09-02 Online:2014-01-31 Published:2014-01-31

摘要: 目的 探讨螺旋断层放疗(HT)治疗肺癌与食管癌致放射性肺炎的发生情况及与双肺剂量体积(DVH)和临床病理特征的关系。方法 回顾性分析HT 治疗的19例肺癌和14食管癌患者的临床资料。全组患者中13例仅行HT治疗,20例联合化疗。放疗剂量:小细胞肺癌54~61.8Gy/27~28次,非小细胞肺癌54~66Gy/25~31次,食管癌60~66Gy/28~30次。结果 全组33例患者中,发生0级放射性肺炎8例(24.2%),1级15例(45.4%),2级1例(3.0%),3级5例(15.2%),5级4例(12.1%)。DVH参数分析显示,发生≥2级放射性肺炎与V30~V45有关,与V5~V25、双肺平均剂量(MLD)、计划靶区(PTV)无关。临床病理特征中,发生≥2级放射性肺炎与ECOG评分有关,与病种、性别、年龄、吸烟、慢性阻塞性肺病和化疗情况无关。结论 HT治疗肺癌与食管癌未明显增加放射性肺炎的发生率,一般状态差、分期晚的患者应严格限制DVH。

Abstract: bjective To investigate the incidence of radiation pneumonitis(RP)in patients with lung cancer and esophageal cancer irradiated with helical tomotherapy(HT) and the occurrence of RP with dose volume histogram(DVH)and clinicopathologic features. Methods Nineteen lung cancer and 14 esophageal cancer patients treated by HT were analyzed retrospectively. Thirteen of the 33 patients received HT alone and 20 patients were treated in combination with chemotherapy. Radiotherapy was delivered to total dose of 54-61.8Gy/27-28f,54-66Gy/25-31f and 60-66Gy/28-30f for small cell lung cancer,non-small cell lung cancer and esophageal cancer. Results RP grade of 0, 1, 2, 3 and 5 occurred in 8(24.2%),15(45.4%),1(3.0%),5(15.2%) and 4(12.1%)cases in all the patients,respectively. DVH parameters analysis showed that≥grade 2 RP was associated with V30-V45,but not with V5-V25,mean lung dose(MLD)and planning target volume(PTV). Meanwhile,≥grade 2 RP was related to ECOG score,but not with lung cancer/esophageal cancer, gender, age,smoking,chemotherapy and chronic obstructive pulmonary diseases. Conclusion The incidence of RP is not high in patients with lung cancer and esophageal cancer treated by HT. Patients with poor ECOG score and late stage should have even strict limitation of DVH.

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!